Drug nearly doubles survival rate for some pancreatic cancer patients, study finds

Some pancreatic cancer patients are seeing a nearly double rate of survival after using a new drug, according to new research. Dr. Harsh Singh, a program director at the MGB Cancer Institute, joins with more details.